Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.

Angela J. Lumsden, Bruce N. Gray(Royal Perth Hospital), Jim Codde(The University of Notre Dame Australia), Peter H. van der Meide
PubMed
August 30, 1996
Cited by 6

Related Papers

The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
REGRESSION OF LIVER METASTASES FOLLOWING TREATMENT WITH YTTRIUM‐90 MICROSPHERES
|Australian and New Zealand Journal of Surgery|1992|145
Threshold of Pulmonary Hypertension Associated With Increased Mortality
|Journal of the American College of Cardiology|2019|132
Effectiveness of peers in delivering programs or motivating older people to increase their participation in physical activity: Systematic review and meta-analysis
|Journal of Sports Sciences|2017|113